Here’s what we are watching as markets kick into gear Thursday.
—Stock futures slipped as new restrictions to curb the spread of coronavirus sparked concerns about further damage to the economy. Futures tied to the S&P 500 fell 0.5%, pointing to a decline in the gauge after the opening bell. Read our full market wrap here.
—Unemployment data. Jobless claims remained high at around 709,000 last week, but slipped to their lowest level since March, suggesting some workers are finding jobs even as coronavirus cases climb.
Market Movers to Watch
—Moderna climbed 3.2% in offhours trading after the biotech company said the first batch of data from its late-stage test of an experimental Covid-19 vaccine candidate was ready for analysis.
—Travel companies that performed well during Monday’s market rotation after promising vaccine news slipped offhours, with
Delta Air Lines
United Airlines Holdings
Norwegian Cruise Line Holdings
down 3.8% and
Royal Caribbean Group
—Boeing Company dropped 2.4% out of hours after the company said it expects a weaker global market amid the coronavirus pandemic, despite also releasing strong forecasts for China’s aircraft demand.
fell a further 2.7% in offhours trading after dropping 3.9% Wednesday. J.P. Morgan analyst Phil Gresh gave the company a bearish rating yesterday citing concerns over the oil price needed to cover its capital expenditures.
—Bitcoin briefly surged over $16,000 for the first time since 2018 before peeling back.
surged 5.4% ahead of the bell, after diversified industrial company swung to a loss in its latest quarter as expenses grew, but sales surged due to its acquisition of Milacron Holdings.
plunged over 10% premarket after the cannabis company reported a drop in third-quarter revenue that disappointed investors.
‘s U.S.-listed shares advanced around 5% offhours, as the China-based electric vehicle maker reported a more than fourfold jump in third-quarter revenue that beat analysts’ predictions despite posting an overall loss. Other U.S.-listed Chinese tech firms were also climbing, including JD.com and Pinduoduo.
Five Prime Therapeutics
jumped over 21% premarket, after the company reported promising results in preclinical data for its FPA157 anti-tumor treatment.
Must Reads Since You Went To Bed
A Global Asset Management Seoul Korea Magazine